Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is not known to directly cause iron deficiency, and low iron does not appear in the list of recognised side effects in its UK product licence. That said, some people on tirzepatide do report fatigue or changes in appetite that can affect diet quality, and there are indirect reasons why iron levels may shift during treatment. If you are concerned about low iron while taking Mounjaro, the right step is a conversation with your prescriber or GP, ideally with blood tests, rather than self-supplementing. These are prescription-only medicines that require clinical assessment and ongoing review to use safely.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide's UK licence (granted by the MHRA and summarised in the prescribing information on the Electronic Medicines Compendium) does not list iron deficiency or anaemia among its known side effects. The large SURMOUNT-1 clinical trial, which involved thousands of adults over 72 weeks, monitored a wide range of blood markers; iron depletion was not flagged as a consistent finding. So if you have read on a forum that Mounjaro causes low iron, that claim is not currently supported by the clinical data that sits behind the UK licence.
Where the picture gets more nuanced is the indirect pathway. Mounjaro works partly by slowing how quickly food leaves the stomach. For most people that is exactly the point, it curbs hunger and extends the feeling of fullness. But slower gastric emptying also changes the environment in which nutrients, including iron, are absorbed. Iron from food (particularly plant-based iron, known as non-haem iron) needs a reasonably acidic stomach environment to be absorbed efficiently. Any change to gastric motility or acid secretion could, in theory, make a modest difference to absorption, though this has not been demonstrated as a clinically significant problem in the trial data so far.
You can read the NHS's plain-language overview of tirzepatide, including its full side-effect profile, on the NHS medicines page for tirzepatide.
The more documented pathway to low iron during any significant weight-loss programme is a change in what you eat. Mounjaro substantially reduces appetite, in clinical trials, participants were eating considerably less, which is largely how the weight loss occurs. Eating less is fine as a goal, but if the foods that fall away first happen to be iron-rich ones (red meat, lentils, fortified cereals, spinach), your total iron intake drops.
This is not unique to Mounjaro. Anyone eating at a significant calorie deficit needs to be a little more deliberate about nutritional density. A reduced-calorie diet alongside treatment is part of the licensed approach; the question is whether the calories you do eat are carrying enough iron, vitamin B12, and protein to keep your body functioning well. Our general guide to what Mounjaro can cause covers the broader picture of how appetite changes affect everyday nutrition.
If nausea is hitting hard in the early weeks (a common experience when the dose goes up) you may be eating even less than planned, and leaning on bland, easily tolerated foods that tend to be low in iron. That is a temporary but real vulnerability worth being aware of.
Tiredness is listed as a recognised side effect of Mounjaro, most often linked to the gastrointestinal workload in the early dose-increase period. Low iron also causes fatigue, along with breathlessness, pale skin, and difficulty concentrating. The overlap is significant enough that one cannot reliably tell the difference by symptoms alone.
This matters because self-treating with iron supplements without knowing your actual iron level is not without risk. High doses of supplemental iron cause their own gastrointestinal problems (constipation, stomach pain, dark stools) which can compound the GI effects that tirzepatide already produces. If you are also taking oral iron tablets, there is a separate interaction question worth discussing with your prescriber, which is covered in more detail on our page about Mounjaro and iron tablets.
The straightforward answer is a full blood count and serum ferritin test, requested through your GP. These are routine, inexpensive and give you actual data rather than guesswork. If iron deficiency is confirmed, your prescriber can recommend the right form and dose of supplementation, and advise on timing relative to your Mounjaro injection to minimise any absorption interference.
Mounjaro is a prescription-only medicine, and ongoing clinical review is part of how it should be used. At nume, a GPhC-registered prescriber reads your consultation answers and reviews your case before every order, not a piece of software, but a qualified clinician who can flag if symptoms you report are worth investigating further. If fatigue is one of those symptoms, that is exactly the kind of detail that matters at review, and it is worth knowing that some patients also ask broader questions such as whether Mounjaro can cause neurological symptoms like MS, which our clinical team is equally equipped to discuss.
If you are on a regular iron supplement, or if a GP has already flagged low ferritin, mention it in your consultation. It helps the prescriber build an accurate picture of your health alongside weight-management treatment. You can also read more about the full range of conditions our clinical team considers on the Mounjaro treatment overview.
Wondering what all of this means for the cost of treatment? A single transparent price at nume covers consultation, prescription and clinical review. There are no separate charges for the prescriber to ask follow-up questions. For context on how private Mounjaro pricing works more broadly, the Mounjaro price comparison guide sets out what the market looks like and what those prices typically include.
The MHRA's Yellow Card scheme lets you report any unexpected symptoms you experience on a medicine, details at yellowcard.mhra.gov.uk. It is a useful safety net and genuinely helps improve what is known about medicines like tirzepatide over time, including compounded formulations such as Hallandale tirzepatide, which some patients encounter when researching their options.
If you have questions about other possible effects tirzepatide might have, or are wondering about something specific to your situation, our FAQs are a good place to start, and our clinical team is reachable seven days a week. When you are ready to find out whether Mounjaro is clinically suitable for you, check your eligibility with a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.